Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders.
We prospectively studied 50 patients treated with interferon-alpha for chronic hepatitis and found no evidence that patients with a pre-existing mood or anxiety disorder were more likely than other patients to interrupt the interferon-alpha therapy.